Elevated serum WNT11 levels correlate with poor prognosis and immune exclusion signatures in patients with colorectal cancer LM, indicating its potential utility as a minimally invasive diagnostic and predictive tool. This evidence concerns the gene WNT11 and colorectal cancer.